[Chronic morbidities of premature newborns]

György Balla1, Miklós Szabó

  • 1Debreceni Egyetem, Orvos- és Egészségtudományi Centrum Gyermekgyógyászati Intézet Debrecen Nagyerdei krt. 98. 4032.

Orvosi Hetilap
|September 17, 2013
PubMed

Insights

Preventing chronic diseases in premature infants, such as retinopathy of prematurity, is crucial. Understanding pathological angiogenesis, a key risk factor, can improve infant quality of life.

Area of Science:

  • Neonatal Medicine
  • Vascular Biology
  • Pathophysiology

Context:

  • Premature birth rates remain high, necessitating effective prevention strategies for chronic morbidities.
  • Treatments for end-stage disorders in premature infants are challenging.
  • Common risk factors, including pathological angiogenesis, underlie these morbidities.

Purpose:

  • To highlight the significance of prevention for premature newborns' chronic morbidities.
  • To underscore the role of pathological angiogenesis in abnormal vascular growth.
  • To explore mechanisms leading to organ damage in preterm infants.

Summary:

  • Premature infants face chronic morbidities like retinopathy of prematurity and bronchopulmonary dysplasia.
  • Postnatal stress, including relative hyperoxia, injures vascular development.
  • Hypoxia-induced genes trigger pathological neovascularization and organ damage.

Impact:

  • Effective prevention strategies can improve the quality of life for premature infants.
  • Inhibiting reactive neovascularization is key to better outcomes.
  • Detailed knowledge of pathophysiological mechanisms is essential for developing interventions.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...